Novel Thrice-Weekly Isoniazid plus Rifapentine Short-Course Regimen for the Treatment of Latent Tuberculosis Infection in a Murine Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Thrice-Weekly Isoniazid plus Rifapentine Short-Course Regimen for the Treatment of Latent Tuberculosis Infection in a Murine Model

Published:2024-06-12 Issue:3 Volume:4 Page:138-141
ISSN:2096-9511
Container-title:Infectious Diseases & Immunity
language:en
Short-container-title:Infect Dis Immun

Author:

Ruan Qiaoling¹,Zhou Jingyu¹^ORCID,Weng Shufeng,Shao Lingyun¹,Zhang Wenhong

Affiliation:

1. Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference10 articles.

1. Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial;Clin Microbiol Infect,2021

2. Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study;Eur Respir J,2018

3. Systemic reactions to intermittent rifampicin;Bull Int Union Tuberc,1974

4. Preclinical efficacy testing of new drug candidates;Microbiol Spectr,2017

5. Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection;Am J Respir Crit Care Med,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP